Brighter’s Actiste shortlisted for MWC2020 Glomo Awards – Best Mobile Innovation for Health and Biotech
Actiste®, currently being introduced to the global market by Brighter AB (publ) in partnership with Ericsson, has been shortlisted for Mobile World Congress Glomo Awards 2020 in the Best Mobile Innovation for Health and Biotech category.
The annual awards take place at Mobile World Congress Barcelona, and spotlight the most innovative telecoms solutions from industry heavyweights.
Actiste is the world's first complete IoT care solution for monitoring and treating insulin-dependent diabetes. The unit brings together and combine all the necessary functions for diabetes care – blood sampling, blood glucose measurement and drug injection – in a single connected device.
The solution is based on patented technology for collecting data on specified biomarkers and injected volumes of drugs. With state-of-the-art eSIM technology, provided by the industry leading ICT company Ericsson, Actiste has global out-of-the-box connectivity, making it completely independent of other devices to utilize and share health and treatment data. Actiste received two CE-marks in September 2019 - one for MDD and one for IVDD.
The Actiste device is delivered as part of a subscription service. The service includes global connectivity, different levels of data sharing, continuous replenishment of consumables and enables coaching to optimize and improve treatment. https://actiste.com/
For further information, please contact:
Henrik Norström, CEO
+46 733 40 30 45
About Brighter AB (publ)
Brighter is a health-tech company from Sweden with a vision of a world where managing chronic diseases is no longer a struggle. We believe a data-centric approach is key to provide smarter care for chronic conditions. Our daily-care solutions facilitate the flow of real-life treatment data between chronic-disease patients, their loved ones and their care providers – improving quality of life, easing the burden on healthcare systems, and opening new opportunities for data-driven research. Brighter is certified under ISO 13485. In 2019 the company won the Swecare Rising Stars Award.
The Company's shares are listed on Nasdaq First North Growth Market/BRIG.Brighter’s Certified Adviser on Nasdaq OMX First North is Eminova Fondkommission AB, +46 (0)8 – 684 211 10, firstname.lastname@example.org, www.eminova.se.